Respecting cancer drug transportability: a basis for successful lead selection.
Sausville
Edward A
EA
D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000493:pharmacokinetics* / Q000494:pharmacology; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D004195:Disease Models, Animal; D015195:Drug Design; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D011355:Prodrugs / Q000493:pharmacokinetics* / Q000494:pharmacology; D000077704:Tirapazamine; D014227:Triazines / Q000493:pharmacokinetics* / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D018906:Antineoplastic Agents, Alkylating; D011355:Prodrugs; D014227:Triazines; D000077704:Tirapazamine